{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:49Z","timestamp":1786985089272,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bprch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.beha.2017.10.009","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T15:38:14Z","timestamp":1510241894000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of stem cell transplantation in follicular lymphoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Georg","family":"Hess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.beha.2017.10.009_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.V52.1.85.85","article-title":"Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma","volume":"52","author":"Appelbaum","year":"1978","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.beha.2017.10.009_bib2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.beha.2017.10.009_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","article-title":"An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation","volume":"31","author":"Peniket","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.beha.2017.10.009_bib4","first-page":"1832","article-title":"Allogeneic bone marrow transplantation for low-grade lymphoma","volume":"92","author":"van Besien","year":"1998","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2017.10.009_bib5","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1182\/blood.V90.10.4201","article-title":"Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma","volume":"90","author":"Verdonck","year":"1997","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2017.10.009_bib6","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2003-04-1205","article-title":"Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma","volume":"102","author":"van Besien","year":"2003","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.beha.2017.10.009_bib7","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1200\/JCO.2009.26.9100","article-title":"T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma","volume":"28","author":"Thomson","year":"2010","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"21","key":"10.1016\/j.beha.2017.10.009_bib8","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","article-title":"High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial","volume":"21","author":"Schouten","year":"2003","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"10.1016\/j.beha.2017.10.009_bib9","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.2008.18.1495","article-title":"Follicular lymphoma in the United States: first report of the national LymphoCare study","volume":"27","author":"Friedberg","year":"2009","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"18","key":"10.1016\/j.beha.2017.10.009_bib10","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1200\/JCO.2006.09.8327","article-title":"Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up","volume":"25","author":"Rohatiner","year":"2007","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"14","key":"10.1016\/j.beha.2017.10.009_bib11","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1200\/JCO.2010.32.8419","article-title":"Allogeneic transplantation for lymphoma","volume":"29","author":"Chakraverty","year":"2011","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"10.1016\/j.beha.2017.10.009_bib12","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2004-03-0982","article-title":"Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group","volume":"104","author":"Lenz","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2017.10.009_bib13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2008-05-160200","article-title":"High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years","volume":"113","author":"Gyan","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2017.10.009_bib14","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2006-03-013193","volume":"108","author":"Sebban","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2017.10.009_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/jnci\/djr450","article-title":"Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis","volume":"104","author":"Al Khabori","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.beha.2017.10.009_bib16","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1182\/blood-2007-10-116749","volume":"111","author":"Ladetto","year":"2008","journal-title":"Blood"},{"issue":"9759","key":"10.1016\/j.beha.2017.10.009_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","article-title":"Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial","volume":"377","author":"Salles","year":"2011","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.beha.2017.10.009_bib18","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1200\/JCO.2004.04.020","article-title":"Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up","volume":"22","author":"Czuczman","year":"2004","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"10.1016\/j.beha.2017.10.009_bib19","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/sj.leu.2404850","article-title":"Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study","volume":"21","author":"Montoto","year":"2007","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.beha.2017.10.009_bib20","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1200\/JCO.2006.09.8327","article-title":"Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up","volume":"25","author":"Rohatiner","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.beha.2017.10.009_bib21","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1200\/JCO.1993.11.7.1344","article-title":"Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma","volume":"11","author":"Berinstein","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.beha.2017.10.009_bib22","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/annonc\/mdn044","article-title":"Immunochemotherapy with in\u00a0vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma","volume":"19","author":"Arcaini","year":"2008","journal-title":"Ann Oncol Off J Eur Soc Med Oncol\/ESMO"},{"issue":"9","key":"10.1016\/j.beha.2017.10.009_bib23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1703515","article-title":"Rituximab in\u00a0vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL","volume":"29","author":"Flohr","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"10.1016\/j.beha.2017.10.009_bib24","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.2012.47.1862","article-title":"Rituximab purging and\/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation","volume":"31","author":"Pettengell","year":"2013","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.beha.2017.10.009_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00277-014-2288-5","article-title":"Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab","volume":"94","author":"Berinstein","year":"2015","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.beha.2017.10.009_bib26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00277-016-2705-z","article-title":"Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience","volume":"95","author":"Bourcier","year":"2016","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.beha.2017.10.009_bib27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3324\/haematol.2010.030320","article-title":"Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA\/GOELAMS FL2000 study","volume":"96","author":"Le Gouill","year":"2011","journal-title":"Haematologica"},{"issue":"24","key":"10.1016\/j.beha.2017.10.009_bib28","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1200\/JCO.2004.06.016","volume":"22","author":"Lenz","year":"2004","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"10.1016\/j.beha.2017.10.009_bib29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bmt.2012.182","article-title":"Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?","volume":"48","author":"Hamadani","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.beha.2017.10.009_bib30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1053\/bbmt.1999.v5.pm10465106","article-title":"Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies","volume":"5","author":"Friedberg","year":"1999","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.beha.2017.10.009_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2141.2001.02705.x","article-title":"Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma","volume":"113","author":"Chen","year":"2001","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.beha.2017.10.009_bib32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbmt.2007.04.009","article-title":"A\u00a015-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma","volume":"13","author":"Sabloff","year":"2007","journal-title":"Biol blood marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.beha.2017.10.009_bib33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2141.2010.08519.x","article-title":"High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study","volume":"152","author":"Eide","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.beha.2017.10.009_bib34","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3109\/10428194.2012.656637","article-title":"Is autologous stem cell transplantation for transformed follicular lymphoma still justifiable?","volume":"53","author":"Dickinson","year":"2012","journal-title":"Leukemia lymphoma"},{"issue":"20","key":"10.1016\/j.beha.2017.10.009_bib35","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1200\/JCO.2003.08.054","volume":"21","author":"Bierman","year":"2003","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.beha.2017.10.009_bib36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2141.2009.07905.x","article-title":"Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation","volume":"147","author":"Avivi","year":"2009","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.beha.2017.10.009_bib37","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/bmt.2013.83","article-title":"The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT","volume":"48","author":"Robinson","year":"2013","journal-title":"Bone marrow Transplant"},{"issue":"12","key":"10.1016\/j.beha.2017.10.009_bib38","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1182\/blood-2008-01-136242","article-title":"Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab","volume":"111","author":"Khouri","year":"2008","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.beha.2017.10.009_bib39","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood-2015-11-624320","article-title":"The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphoma","volume":"127","author":"Kuruvilla","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2017.10.009_bib40","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.bbmt.2015.07.028","article-title":"Reduced-intensity allografting as first transplantation approach in relapsed\/refractory grades one and two follicular lymphoma provides improved outcomes in long-term survivors","volume":"21","author":"Klyuchnikov","year":"2015","journal-title":"Biol blood marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.beha.2017.10.009_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/bmt.2015.223","article-title":"Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma","volume":"51","author":"Klyuchnikov","year":"2016","journal-title":"Bone marrow Transplant"},{"issue":"9","key":"10.1016\/j.beha.2017.10.009_bib42","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.2012.44.0693","article-title":"Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group","volume":"31","author":"Villa","year":"2013","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"25","key":"10.1016\/j.beha.2017.10.009_bib43","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1200\/JCO.2013.50.2245","article-title":"Chemotherapy versus autologous stem-cell transplantation for the treatment of transformed follicular lymphoma in the rituximab era","volume":"31","author":"Tam","year":"2013","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"10.1016\/j.beha.2017.10.009_bib44","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00277-011-1395-9","article-title":"Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study","volume":"91","author":"Rigacci","year":"2012","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.beha.2017.10.009_bib45","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3324\/haematol.2013.084723","article-title":"Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party","volume":"98","author":"Montoto","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.beha.2017.10.009_bib46","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2006-01-013367","volume":"108","author":"Buske","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2017.10.009_bib47","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2017.10.009_bib48","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.beha.2017.10.009_bib49","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","article-title":"Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy","volume":"128","author":"Jurinovic","year":"2016","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.beha.2017.10.009_bib50","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","article-title":"Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the national LymphoCare study","volume":"33","author":"Casulo","year":"2015","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"10","key":"10.1016\/j.beha.2017.10.009_bib51","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1182\/blood-2004-10-3920","article-title":"High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS","volume":"105","author":"Deconinck","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2017.10.009_bib52","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.bbmt.2017.05.021","article-title":"Autologous stem cell transplantation for follicular lymphoma: favorable long-term survival irrespective of pretransplantation rituximab exposure","volume":"23","author":"Jimenez-Ubieto","year":"2017","journal-title":"Biol blood marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.beha.2017.10.009_bib53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ajh.23919","article-title":"Autologous stem cell transplantation with in\u00a0vivo purged progenitor cells shows long-term efficacy in relapsed\/refractory follicular lymphoma","volume":"90","author":"Arcaini","year":"2015","journal-title":"Am J Hematol"},{"issue":"21","key":"10.1016\/j.beha.2017.10.009_bib54","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1200\/JCO.2007.15.5358","article-title":"Impact of rituximab and\/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study","volume":"26","author":"Sebban","year":"2008","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"20","key":"10.1016\/j.beha.2017.10.009_bib55","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1002\/cncr.28243","article-title":"Stem cell transplantation for follicular lymphoma relapsed\/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project","volume":"119","author":"Evens","year":"2013","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.beha.2017.10.009_bib56","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/annonc\/mdu440","article-title":"The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party","volume":"25","author":"El-Najjar","year":"2014","journal-title":"Ann Oncol Off J Eur Soc Med Oncol\/ESMO"},{"issue":"1","key":"10.1016\/j.beha.2017.10.009_bib57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/10428194.2014.911866","article-title":"Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity","volume":"56","author":"Phipps","year":"2015","journal-title":"Leukemia lymphoma"},{"issue":"7","key":"10.1016\/j.beha.2017.10.009_bib58","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood.V74.7.2579.2579","article-title":"Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation","volume":"74","author":"Schouten","year":"1989","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2017.10.009_bib59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.2001.19.3.727","article-title":"High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry","volume":"19","author":"Williams","year":"2001","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"10.1016\/j.beha.2017.10.009_bib60","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.bmt.1705178","article-title":"Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma","volume":"36","author":"Andreadis","year":"2005","journal-title":"Bone marrow Transplant"},{"issue":"6","key":"10.1016\/j.beha.2017.10.009_bib61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0609.2008.01146.x","article-title":"High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma","volume":"81","author":"Hamadani","year":"2008","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.beha.2017.10.009_bib62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1200\/JCO.2007.11.5477","article-title":"Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-hodgkin's lymphoma","volume":"26","author":"Revzani","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.beha.2017.10.009_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbmt.2007.11.004","article-title":"Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning","volume":"14","author":"Hari","year":"2008","journal-title":"Biol blood marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.beha.2017.10.009_bib64","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3324\/haematol.2009.017608","article-title":"Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials","volume":"95","author":"Pinana","year":"2010","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.beha.2017.10.009_bib65","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbmt.2010.11.004","article-title":"Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response","volume":"17","author":"Tomblyn","year":"2011","journal-title":"Biol blood marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.beha.2017.10.009_bib66","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bjh.13947","article-title":"The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of <\/=12 months","volume":"173","author":"Lunning","year":"2016","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.beha.2017.10.009_bib67","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/bmt.2015.158","article-title":"Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed\/refractory follicular lymphoma","volume":"50","author":"Yano","year":"2015","journal-title":"Bone marrow Transplant"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692617300701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692617300701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T09:45:04Z","timestamp":1603273504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692617300701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1521692617300701"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2017.10.009","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of stem cell transplantation in follicular lymphoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2017.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}